[HTML][HTML] Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy
Immunotherapy fails to cure most cancer patients. Preclinical studies indicate that radiotherapy
synergizes with immunotherapy, promoting radiation-induced antitumor immunity. Most …
synergizes with immunotherapy, promoting radiation-induced antitumor immunity. Most …
Neutrophils promote tumor resistance to radiation therapy
…, DJ Carpenter, KT Kadakia, JE Himes… - Proceedings of the …, 2019 - National Acad Sciences
Nearly two-thirds of cancer patients are treated with radiation therapy (RT), often with the
intent to achieve complete and permanent tumor regression (local control). RT is the primary …
intent to achieve complete and permanent tumor regression (local control). RT is the primary …
[HTML][HTML] The impact of the gut microbiota on humoral immunity to pathogens and vaccination in early infancy
QN Nguyen, JE Himes, DR Martinez… - PLoS …, 2016 - journals.plos.org
There is a new recognition that the gut microbiota, which consists of a dynamic community of
intestinal bacteria, viruses, fungi, and archaea, can impact the development and function of …
intestinal bacteria, viruses, fungi, and archaea, can impact the development and function of …
[HTML][HTML] Polyclonal HIV envelope-specific breast milk antibodies limit founder SHIV acquisition and cell-associated virus loads in infant rhesus monkeys
Breast milk HIV-1 transmission is currently the predominant contributor to pediatric HIV
infections. Yet, only ~10% of breastfeeding infants born to untreated HIV-infected mothers …
infections. Yet, only ~10% of breastfeeding infants born to untreated HIV-infected mothers …
[HTML][HTML] Relationship between the tumor microenvironment and the efficacy of the combination of radiotherapy and immunotherapy
C Su, JE Himes, DG Kirsch - … review of cell and molecular biology, 2023 - ncbi.nlm.nih.gov
Activating and recruiting the immune system is critical for successful cancer treatment. Since
the discovery of immune checkpoint inhibitors, immunotherapy has become the standard of …
the discovery of immune checkpoint inhibitors, immunotherapy has become the standard of …
Neoadjuvant radiation therapy and surgery improves metastasis-free survival over surgery alone in a primary mouse model of soft tissue sarcoma
…, M Holbrook, ES Xu, CS Hong, JE Himes… - Molecular cancer …, 2023 - AACR
… JE Himes reports grants from NIH during the conduct of the study. DG Kirsch reports grants
from XRAD Therapeutics, Bristol-Myers Squibb, Varian Medical Systems, and Eli Lilly during …
from XRAD Therapeutics, Bristol-Myers Squibb, Varian Medical Systems, and Eli Lilly during …
Sperm chemotaxis as revealed with live and synthetic eggs
JE Himes, JA Riffell, CA Zimmer… - The Biological …, 2011 - journals.uchicago.edu
Fertilization is one of the least understood fundamental biological processes. How sperm
search for and find an egg remains enigmatic. Sperm attraction to egg-derived chemical cues …
search for and find an egg remains enigmatic. Sperm attraction to egg-derived chemical cues …
[HTML][HTML] Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virus
…, A Foulger, JD Amos, R Parks, JE Himes… - Nature …, 2016 - nature.com
African green monkeys (AGMs) are natural primate hosts of simian immunodeficiency virus (SIV).
Interestingly, features of the envelope-specific antibody responses in SIV-infected …
Interestingly, features of the envelope-specific antibody responses in SIV-infected …
Rapid development of gp120-focused neutralizing B cell responses during acute simian immunodeficiency virus infection of African green monkeys
JD Amos, JE Himes, L Armand, TC Gurley… - Journal of …, 2015 - Am Soc Microbiol
The initial phases of acute human immunodeficiency virus type 1 (HIV-1) infection may be
critical for development of effective envelope (Env)-specific antibodies capable of impeding …
critical for development of effective envelope (Env)-specific antibodies capable of impeding …
Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma
…, J Chen, ML Ravotti, ES Xu, JE Himes… - International Journal of …, 2024 - Elsevier
Purpose Despite aggressive multimodal treatment that typically includes definitive or adjuvant
radiation therapy (RT), locoregional recurrence rates approach 50% for patients with …
radiation therapy (RT), locoregional recurrence rates approach 50% for patients with …